103 related articles for article (PubMed ID: 20032125)
1. Discordant expression of molecular markers between primary and nodal metastases: a histopathological manifestation of the 'self (stem cell)-seeding' nature of breast cancer disease?
Lopez-Bonet E; Menendez JA
Ann Oncol; 2010 Apr; 21(4):901-902. PubMed ID: 20032125
[No Abstract] [Full Text] [Related]
2. Reply to: discordant expression of molecular markers between primary and nodal metastases: a histopathological manifestation of the 'self (stem cell)-seeding' nature of breast cancer disease?
Faratian D; Aitken SJ; Thomas JS; Langdon SP; Harrison DJ
Ann Oncol; 2010 Jun; 21(6):1375. PubMed ID: 20215137
[No Abstract] [Full Text] [Related]
3. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
[TBL] [Abstract][Full Text] [Related]
4. Is initially metastatic breast carcinoma different from recurrent metastatic breast carcinoma?
Dizdar O; Aksoy S; Altundag K
Ann Oncol; 2009 Jan; 20(1):189; author reply 189-90. PubMed ID: 18820244
[No Abstract] [Full Text] [Related]
5. Molecular alterations in metaplastic breast carcinoma.
Cooper CL; Karim RZ; Selinger C; Carmalt H; Lee CS; O'Toole SA
J Clin Pathol; 2013 Jun; 66(6):522-8. PubMed ID: 23372178
[TBL] [Abstract][Full Text] [Related]
6. Specific cell differentiation in breast cancer: a basis for histological classification.
Rakha E; Toss M; Quinn C
J Clin Pathol; 2022 Feb; 75(2):76-84. PubMed ID: 34321225
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer survival and immunohistochemical similarities between primary and metastatic sites, as a surrogate marker for the cancer self-seeding.
Kurbel S; Dmitrovic B; Tomas I; Kristek J; Bozac M
Int J Biol Markers; 2012 Jul; 27(2):e167-8. PubMed ID: 22653743
[No Abstract] [Full Text] [Related]
8. Modulation of tumorigenesis and oestrogen receptor-alpha expression by cell culture conditions in a stem cell-derived breast epithelial cell line.
Wang KH; Kao AP; Chang CC; Lee JN; Chai CY; Hou MF; Liu CM; Tsai EM
Biol Cell; 2010 Jan; 102(3):159-72. PubMed ID: 19895368
[TBL] [Abstract][Full Text] [Related]
9. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line.
Wang X; Liu Y; Zhou K; Zhang G; Wang F; Ren J
Int J Clin Exp Pathol; 2015; 8(5):5105-12. PubMed ID: 26191205
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
12. Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.
Tominaga K; Shimamura T; Kimura N; Murayama T; Matsubara D; Kanauchi H; Niida A; Shimizu S; Nishioka K; Tsuji EI; Yano M; Sugano S; Shimono Y; Ishii H; Saya H; Mori M; Akashi K; Tada KI; Ogawa T; Tojo A; Miyano S; Gotoh N
Oncogene; 2017 Mar; 36(9):1276-1286. PubMed ID: 27546618
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of the role and relationship between Notch-1 and Oct-4 expression in urinary bladder carcinoma.
Abdou AG; El-Wahed MM; Kandil MA; Samaka RM; Elkady N
APMIS; 2013 Oct; 121(10):982-96. PubMed ID: 23594289
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome.
Wang L; Peng L; Dong B; Kong L; Meng L; Yan L; Xie Y; Shou C
Ann Oncol; 2006 Oct; 17(10):1517-22. PubMed ID: 16873432
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.
Joseph C; Arshad M; Kurozomi S; Althobiti M; Miligy IM; Al-Izzi S; Toss MS; Goh FQ; Johnston SJ; Martin SG; Ellis IO; Mongan NP; Green AR; Rakha EA
Breast Cancer Res Treat; 2019 Apr; 174(2):387-399. PubMed ID: 30554343
[TBL] [Abstract][Full Text] [Related]
16. Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastases.
Huang YH; Luo MH; Ni YB; Tsang JY; Chan SK; Lui PC; Yu AM; Tan PH; Tse GM
Histopathology; 2014 Mar; 64(4):494-503. PubMed ID: 24382260
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer stem cells: a case of mistaken identity?
Polyak K
Stem Cell Rev; 2007 Jun; 3(2):107-9. PubMed ID: 17873341
[No Abstract] [Full Text] [Related]
18. Breast cancer stem cells: the other side of the story.
Wicha MS
Stem Cell Rev; 2007 Jun; 3(2):110-2; discussion 113. PubMed ID: 17873342
[No Abstract] [Full Text] [Related]
19. Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.
España L; Martín B; Aragüés R; Chiva C; Oliva B; Andreu D; Sierra A
Am J Pathol; 2005 Oct; 167(4):1125-37. PubMed ID: 16192647
[TBL] [Abstract][Full Text] [Related]
20. Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer.
Kündig P; Giesen C; Jackson H; Bodenmiller B; Papassotirolopus B; Freiberger SN; Aquino C; Opitz L; Varga Z
J Transl Med; 2018 May; 16(1):118. PubMed ID: 29739401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
